1155P Updated results of surufatinib plus transarterial embolization versus surufatinib monotherapy in neuroendocrine tumor with liver metastasis: A prospective, randomized, controlled trial

Dedong Cao(Wuhan University), Nan Rosemary Ke(Sichuan University), Xiaodong Li(Stomatology Hospital), Rong Li(University of Science and Technology of China), Xin You(Ministry of Education of the People's Republic of China), Haitao Lan(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Jing Wang(Tongji Hospital), Jenny Xiang(Cornell University)
Annals of Oncology
September 1, 2024
Cited by 0


Related Papers